Referred to the House Committee on Energy and Commerce.
This resolution expresses the House of Representatives' support for designating June 1-7, 2026 as Hidradenitis Suppurativa Awareness Week and urges increased awareness, research, and better access to care for people with the disease. It is a formal statement by the House highlighting the importance of early diagnosis, treatment options, and policy attention. The resolution does not create new legal rights or change federal law. It is a nonbinding way for the House to encourage public awareness, medical research, and policy action.
This is a simple resolution introduced in the House and, if adopted, would reflect only the House's position; it does not go to the Senate or the President and does not have the force of law.
This House resolution expresses support for designating June 1–7, 2026, as Hidradenitis Suppurativa (HS) Awareness Week.
It summarizes HS impacts, highlights gaps in diagnosis and treatment, urges more research and improved access to therapies, and calls for public and professional education.
The resolution is nonbinding and primarily symbolic, recognizing the role federal policy can play in improving care and access.
H.Res. is symbolic and not a statute; adoption by the House is likely, but it cannot become law and Senate enactment is improbable absent a companion.
Relative to its intended legislative type, this bill functions as a typical commemorative resolution: it clearly defines the condition being recognized, designates specific dates for awareness activities, and enumerates desirable focal areas (awareness, diagnosis, research, access) but does not create legal duties, funding, or enforcement mechanisms.
Liberals push for research funding and access; conservatives worry about federal mandates.
These are examples from the analysis, not a ranked list of the most-affected groups.
Liberals push for research funding and access; conservatives worry about federal mandates.
Likely strongly supportive.
Views the resolution as a needed step to highlight a painful, underdiagnosed disease and to justify increased research and access efforts.
Sees potential to mobilize funding and policy changes addressing health equity and mental health.
Generally supportive but pragmatic.
Sees value in raising awareness and improving diagnosis, while emphasizing the resolution is symbolic.
Wants clear, costed follow-up actions and measurable outcomes before endorsing policy changes or spending.
Cautiously accepting of the awareness designation as a low-cost, nonbinding measure but wary of implications.
Supports attention to suffering individuals but is concerned about expanded federal intervention, potential mandates, and increased spending on biologics.
Reached or meaningfully advanced
Reached or meaningfully advanced
Still ahead
Still ahead
Still ahead
H.Res. is symbolic and not a statute; adoption by the House is likely, but it cannot become law and Senate enactment is improbable absent a companion.
The bill has not accumulated any surfaced votes yet.
Liberals push for research funding and access; conservatives worry about federal mandates.
H.Res. is symbolic and not a statute; adoption by the House is likely, but it cannot become law and Senate enactment is improbable absent a…
Relative to its intended legislative type, this bill functions as a typical commemorative resolution: it clearly defines the condition being recognized, designates specific dates for awareness activities, and enumerates…
Go beyond the headline summary with full stakeholder mapping, legislative design analysis, passage barriers, and lens-by-lens tradeoff breakdowns.